Bures-sur-Yvette, France

Gérard Ulibarri


Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 115(Granted Patents)


Location History:

  • Burcs-sur-Yvette, FR (2003)
  • Burres-sur-Yvette, FR (2002 - 2004)
  • Ottawa, CA (2004)
  • Fraze, FR (2004)

Company Filing History:


Years Active: 2002-2004

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Gérard Ulibarri: Innovator in Medicinal Chemistry

Introduction

Gérard Ulibarri is a notable inventor based in Bures-sur-Yvette, France. He has made significant contributions to the field of medicinal chemistry, holding a total of 7 patents. His work primarily focuses on the development of innovative pharmaceutical compounds.

Latest Patents

Among his latest patents are several groundbreaking inventions. These include "Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them," "Derivatives of N-(iminomethy)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them," and "N-(imino)amines and their preparation and their use as NO synthase inhibitors and selective or non-selective traps for a reactive oxygen species." These patents reflect his commitment to advancing medical science through innovative solutions.

Career Highlights

Throughout his career, Gérard Ulibarri has worked with various organizations, including Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.). His expertise in medicinal chemistry has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Gérard has collaborated with esteemed colleagues such as Serge Auvin and Pierre-Etienne Chabrier De Lassauniere. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

Gérard Ulibarri's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…